CELLBRICATE
Live / Applied — Non-final action written — not yet mailed (as of 20 Nov 2026)
Now
Refused for now — an office action was mailed 20 Nov 2026.
A response is due by 20 May 2027; with no response the application is abandoned.
What this means for you
Not registered yet, but its 05 Aug 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79458970
- Mark type
- Word mark
- Kind
- Trademark and service mark
- Register
- Principal
- Basis
- Madrid Protocol (§66(a))
- International registration
- 1938957
- Filed
- 05 Aug 2026
- Examining attorney
- Susan K. Lawrence
Goods and services
- Class 001 — Chemicals: Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research; chemical reagents for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; kits containing chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the activation or stimulation of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.
- Class 009 — Scientific and electric apparatus: Laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; scientific apparatus for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, the apparatus including a body fluid collection unit, a cell processing unit and a unit for releasing the manufactured cellular therapy unit; scientific apparatus for the washing of cells obtained from a biological sample, in particular for washing of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells, apparatus of activation or stimulation of cells, and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.
- Class 042 — Scientific and technological services: Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.
Owner
Prosecution history
- 21 Nov 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 20 Nov 2026 — NON-FINAL ACTION WRITTEN
- 19 Nov 2026 — ASSIGNED TO EXAMINER
- 25 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 25 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Sept 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB